Local Bacteriophage Delivery for Treatment and Prevention of Bacterial Infections

As viruses with high specificity for their bacterial hosts, bacteriophages (phages) are an attractive means to eradicate bacteria, and their potential has been recognized by a broad range of industries. Against a background of increasing rates of antibiotic resistance in pathogenic bacteria, bacteri...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in microbiology Vol. 11; p. 538060
Main Authors: Rotman, Stijn Gerard, Sumrall, Eric, Ziadlou, Reihane, Grijpma, Dirk W, Richards, Robert Geoff, Eglin, David, Moriarty, Thomas Fintan
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 18-09-2020
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As viruses with high specificity for their bacterial hosts, bacteriophages (phages) are an attractive means to eradicate bacteria, and their potential has been recognized by a broad range of industries. Against a background of increasing rates of antibiotic resistance in pathogenic bacteria, bacteriophages have received much attention as a possible "last-resort" strategy to treat infections. The use of bacteriophages in human patients is limited by their sensitivity to acidic pH, enzymatic attack and short serum half-life. Loading phage within a biomaterial can shield the incorporated phage against many of these harmful environmental factors, and in addition, provide controlled release for prolonged therapeutic activity. In this review, we assess the different classes of biomaterials (i.e., biopolymers, synthetic polymers, and ceramics) that have been used for phage delivery and describe the processing methodologies that are compatible with phage embedding or encapsulation. We also elaborate on the clinical or pre-clinical data generated using these materials. While a primary focus is placed on the application of phage-loaded materials for treatment of infection, we also include studies from other translatable fields such as food preservation and animal husbandry. Finally, we summarize trends in the literature and identify current barriers that currently prevent clinical application of phage-loaded biomaterials.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Edited by: Karl Kuchler, Medical University of Vienna, Austria
This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology
Reviewed by: Takehiko Kenzaka, Osaka Ohtani University, Japan; Thomas Dandekar, Julius-Maximilian-University of Würzburg, Germany
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2020.538060